Legal Opinion Letters

February 28, 2003

Legal Opinion Letters

FDA Must Clarify Drug Makers’ Ability To Publicly Defend Products

Download the PDF

By Kathleen M. Sanzo, and Stephen Paul Mahinka, partners in the Washington, D.C. office of the law firm of Morgan Lewis, LLP.

Related Content

Legal Opinion Letters

September 20, 2002

Kasky v. Nike: U.S. Supreme Court Review Can Protect Free Public Debate

By Clark S. Judge, the Managing Director of White House Writers Group, a communications and policy consulting firm based in Washington, DC.

Legal Backgrounders

August 23, 2002

An FDA Q&A: How Does The First Amendment Limit Its Regulatory Power?

By Alan R. Bennett, a partner in the Washington, D.C. office of the law firm Ropes & Gray, and Kenneth P. Berkowitz, President of KPB Associates, a Washington, D.C. consulting firm specializing in the regulation of medical communications.

Legal Opinion Letters

July 12, 2002

State High Court Silences Businesses’ Free Speech

By John J. Walsh, Senior Counsel to the New York City Law firm Carter Ledyard & Milburn.